Home ›
Trademark Categories ›
Science & Technology Services ›
2021 ›
GE ›
GENE THERAPY - EVOLVED
Trademark search for:
GENE THERAPY - EVOLVED
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-02-08 — Application filed
2021-02-11 — Application filed
2021-05-12 — Application filed
2021-09-01 — Assigned to examiner
2021-09-09 — Examiners amendment -written
2021-09-09 — Examiners amendment e-mailed
2021-09-09 — Notification of examiners amendment e-mailed
2021-09-09 — Examiner's amendment entered
2021-09-09 — Approved for pub - principal register
2021-09-29 — Notification of notice of publication e-mailed
2021-10-19 — Published for opposition
2021-10-19 — Official gazette publication confirmation e-mailed
2021-12-14 — Noa e-mailed - sou required from applicant
2022-05-26 — Teas change of owner address received
2022-05-26 — Teas change of correspondence received
2022-05-26 — Applicant/correspondence changes (non-responsive) entered
2022-06-09 — Sou teas extension received
2022-06-09 — Sou extension 1 filed
2022-06-09 — Sou extension 1 granted
2022-06-11 — Notice of approval of extension request e-mailed
2022-12-12 — Sou teas extension received
2022-12-12 — Sou extension 2 filed
2022-12-12 — Sou extension 2 granted
2022-12-14 — Notice of approval of extension request e-mailed
2023-04-15 — Teas change of owner address received
2023-04-15 — Teas change of correspondence received
2023-04-15 — Applicant/correspondence changes (non-responsive) entered
2023-06-13 — Sou teas extension received
2023-06-13 — Sou extension 3 filed
2023-06-13 — Sou extension 3 granted
2023-06-15 — Notice of approval of extension request e-mailed
2023-12-04 — Sou extension 4 filed
2023-12-04 — Sou extension 4 granted
2023-12-06 — Notice of approval of extension request e-mailed
2024-02-28 — Teas change of correspondence received
2024-02-28 — Teas change of owner address received
2024-02-28 — Applicant/correspondence changes (non-responsive) entered
2024-06-04 — Sou teas extension received
2024-06-04 — Sou extension 5 granted
2024-06-04 — Sou extension 5 filed
2024-06-13 — Notice of approval of extension request e-mailed
2025-10-01 — Application abandoned
2025-10-01 — Application abandoned
2025-10-01 — Final status recorded
Owner Information
Saliogen Therapeutics, Inc.
Saliogen Therapeutics, Inc.
Correspondent
Rachelle A. Dubow, Esq.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
